Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aetna To Buy Coventry For $5.6 Billion To Add Medicare Plans
Bloomberg
Monday, August 20, 2012 - 10:57am
tags:
Coventry Healthcare, Aetna, M&A, Medicare
Dendreon's Provenge: Early Stage Use
Seeking Alpha
Monday, August 20, 2012 - 10:51am
tags:
Provenge, prostate cancer, Dendreon, JNJ
New coupons aim to keep people off generic drugs
Yahoo/AP
Monday, August 20, 2012 - 10:49am
tags:
generics, drug coupons, Pfizer, Lipitor, Plavix, Bristol-Myers Squibb
Novartis, A Gleevec Patent & India: Herrling Explains
Pharmalot
Monday, August 20, 2012 - 10:39am
tags:
India, Novartis, Gleevec
ARIAD Begins Phase 1/2 Trial of Ponatinib in Japan
Yahoo
Monday, August 20, 2012 - 10:33am
tags:
Ariad Pharmaceuticals, Japan, Ponatinib
8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha
Monday, August 20, 2012 - 10:32am
tags:
Affymax, Alnylam, Arena Pharmaceuticals, Aveo, BioTime, ChemoCentryx, Emergent BioSolutions, Clovis Oncology, Enzon, Forest Labs, Geron, ViroPharma, Targacept, GSK, Pfizer, Santarus, PDL Biopharma, Infinity Pharmaceuticals, Nektar
Celgene may purchase $4.9M in additional shares of Globelmmune
The Fly on the Wall
Monday, August 20, 2012 - 10:28am
tags:
Celgene, GlobeImmune, M&A
Dendreon Provenge Sales Wobbling
Seeking Alpha
Monday, August 20, 2012 - 10:23am
tags:
prostage cancer, Dendreon, Provenge
Biostar Pharmaceuticals receives Army New Drug Certificate in China for Zushima spray
Yahoo/Fly on the Wall
Monday, August 20, 2012 - 10:21am
tags:
Biostar Pharmaceuticals, Zushima, China
Is The Healthcare Sector In A Bright Spot?
Seeking Alpha
Sunday, August 19, 2012 - 11:39am
tags:
Merck, Pfizer, generics, Teva Pharmaceuticals
This Fast Growing, Speculative $3 Medtech Stock Has Strong Upside And Insider Buying
Seeking Alpha
Sunday, August 19, 2012 - 11:34am
tags:
Unilife
Amgen: When Buybacks Work
Seeking Alpha
Sunday, August 19, 2012 - 11:33am
tags:
Amgen
3 Drug Companies That Want to Lose
Motley Fool
Sunday, August 19, 2012 - 11:32am
tags:
Arena, Vivus, Orexigen, obesity, weight loss, Belviq, Qsymia, Contrave, Empatic
5 Pharmaceutical Companies With Insider Buying During August 14-16
Seeking Alpha
Sunday, August 19, 2012 - 11:30am
tags:
Clovis Oncology, Depomed, Inovio, Furiex Pharmaceuticals, OncoGenex
Guilt by Association = 30% Slaughter?
Motley Fool
Sunday, August 19, 2012 - 11:27am
tags:
IDX184, hepatitis C, Idenix, GS-7977, Gilead Sciences, Vertex Pharmaceuticals
Hepatitis C testing may lift Vertex’s market
The Boston Globe, MA
Saturday, August 18, 2012 - 4:21pm
tags:
hepatitis C, Vertex, Incivek
BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering
Enhanced Online News
Saturday, August 18, 2012 - 4:19pm
tags:
BioSante
Watson Pharma Sues FDA
Zacks
Saturday, August 18, 2012 - 4:18pm
tags:
Watson Pharmaceuticals, Actos, generics
HgCapital sells Mercury Pharma
The Deal
Saturday, August 18, 2012 - 4:15pm
tags:
Mercury Pharma
Bitter pill
Business Standard, India
Saturday, August 18, 2012 - 4:13pm
tags:
generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.